$92.05 - PVLA | Palvella Therapeutics, Inc. Common Stock

Palvella Therapeutics, Inc. Common Stock (PVLA)

Palvella Therapeutics, Inc. Common Stock

XNAS:PVLA

92.05

-6.62%

Ask

$92.05 - 200.00

Bid

$90.78 - 3.00

Low

$84.7

High

$112

Open

$109.01

Prev Close

$98.58

52W High

112

52W Low

11.17

Volume

484600

Avg Vol (3m)

187705

Float

8083145.85

Chart

TendieTensor AI Analysis

Company

Asset Type: Common Stock

SIC Code: 2834

Sector: Health Technology

Industry: Biotechnology

Date Listed: 12/16/2024

Primary Exchange: XNAS

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

Phone: (484) 253-1461

Address: 125 Strafford Ave

Address 2: Suite 360

City: Wayne

State: PA

Postal Code: 19087

Website

TendieTensor AI Analyst Recommendation: —

Fundamentals

Total Employees:

P/E (TTM)

-7.820000

P/B (TTM)

28.258300

Round Lot

100

Composit FIGI

BBG0055C3N57

Share Class FIGI

BBG0055C3N66

Share Class Shares Outstanding

11.06M

Weighted Shares Outstanding

11.06M

Technicals

RSI (14)

MACD Line

MACD Signal

SMA 20

SMA 50

EMA 50

Trend

Short Interest

—

Days to Cover

— —

Higher = harder to cover

Short Interest Δ

—

Prev: —

Short Volume Ratio (Today)

— —

5D avg: —

Squeeze Score (0–100)

—

Discussion